Amgen (AMGN) Declares $1.76 Quarterly Dividend; 3.1% Yield

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Amgen (AMGN) Declares $1.76 Quarterly Dividend; 3.1% Yield

Amgen (AMGN) Announces BLINCYTO Demonstrated Significantly Prolonged Event-Free Survival Compared With Consolidation Chemotherapy In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia

March 2, 2021 4:00 PM EST

Amgen (NASDAQ: AMGN) today announced that data from a multicenter, randomized Phase 3 study evaluating the efficacy, safety and tolerability of BLINCYTO® (blinatumomab) compared with consolidation chemotherapy before allogeneic hematopoietic stem cell transplantation (alloHSCT) in pediatric patients with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia (B-ALL) were published in The Journal of the American Medical Association (JAMA).1

BLINCYTO demonstrated significantly prolonged event-free survival (events were defined by relapse, death, second malignancy, or failure to achieve complete remission) compared with chemotherapy. After a median of 22.4 months follow-up, 69% of patients treated with BLINCYTO... More

Amgen (AMGN) PT Raised to $263 at Truist Securities

March 1, 2021 7:12 AM EST

Truist Securities analyst Robyn Karnauskas raised the price target on Amgen (NASDAQ: AMGN) to $263.00 (from $260.00) while maintaining a Hold rating.... More